Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
The self-peptide repertoire plays a critical role in transplant tolerance induction
Eric T. Son, Pouya Faridi, Moumita Paul-Heng, Mario L. Leong, Kieran English, Sri H. Ramarathinam, Asolina Braun, Nadine L. Dudek, Ian E. Alexander, Leszek Lisowski, Patrick Bertolino, David G. Bowen, Anthony W. Purcell, Nicole A. Mifsud, Alexandra F. Sharland
Eric T. Son, Pouya Faridi, Moumita Paul-Heng, Mario L. Leong, Kieran English, Sri H. Ramarathinam, Asolina Braun, Nadine L. Dudek, Ian E. Alexander, Leszek Lisowski, Patrick Bertolino, David G. Bowen, Anthony W. Purcell, Nicole A. Mifsud, Alexandra F. Sharland
View: Text | PDF
Research Article Immunology

The self-peptide repertoire plays a critical role in transplant tolerance induction

  • Text
  • PDF
Abstract

While direct allorecognition underpins both solid organ allograft rejection and tolerance induction, the specific molecular targets of most directly alloreactive CD8+ T cells have not been defined. In this study, we used a combination of genetically engineered major histocompatibility complex class I (MHC I) constructs, mice with a hepatocyte-specific mutation in the class I antigen-presentation pathway, and immunopeptidomic analysis to provide definitive evidence for the contribution of the peptide cargo of allogeneic MHC I molecules to transplant tolerance induction. We established a systematic approach for the discovery of directly recognized pMHC epitopes and identified 17 strongly immunogenic H-2Kb–associated peptides recognized by CD8+ T cells from B10.BR (H-2k) mice, 13 of which were also recognized by BALB/c (H-2d) mice. As few as 5 different tetramers used together were able to identify a high proportion of alloreactive T cells within a polyclonal population, suggesting that there are immunodominant allogeneic MHC-peptide complexes that can account for a large component of the alloresponse.

Authors

Eric T. Son, Pouya Faridi, Moumita Paul-Heng, Mario L. Leong, Kieran English, Sri H. Ramarathinam, Asolina Braun, Nadine L. Dudek, Ian E. Alexander, Leszek Lisowski, Patrick Bertolino, David G. Bowen, Anthony W. Purcell, Nicole A. Mifsud, Alexandra F. Sharland

×

Figure 11

Tracking alloreactive T cells using a tetramer panel.

Options: View larger image (or click on image) Download as PowerPoint
Tracking alloreactive T cells using a tetramer panel.
(A) A 5-tetramer p...
(A) A 5-tetramer panel was used to enumerate and phenotype alloreactive CD8+ T cells in a model of secondary skin graft tolerance or rejection. (B) Secondary skin grafts to control mice were promptly rejected, while grafts performed 7 days after inoculation of primed recipients with AAV-Kb survived indefinitely (n = 6). (C) The number of tet+ cells in pooled SLO expanded 3-fold following rejection of a secondary graft (12,000 ± 1500 versus 31,000 ± 3500 cells, P = 0.0021), but had not increased significantly after graft acceptance (12,000 ± 1500 against 22,000 ± 3700, P = 0.29). (D) Induction of tolerance in primed mice by inoculation with AAV-Kb resulted in a sharp increase of tet+ cells within the liver (from 480 ± 97 to 131,000 ± 22,000 cells, P < 0.0001), declining subsequently. (E) Numbers of tet+ cells in rejecting transplants were similar to those in tolerated grafts on d14 (640 ± 190 versus 400 ± 130 cells, P = 0.78), while few tet+ cells persisted long-term in accepted grafts. (F) Rejecting skin grafts contained a population of CD8+ T cells which stained very strongly with the tetramer panel (representative flow plots from n = 3). (F–H) This tetramer-bright population was not detected in tolerated grafts. (C, D, E, G, and H) Data are shown as mean ± SEM, n = 3/group. (C–E) One-way ANOVA in conjunction with Sidak’s multiple comparison test, (H) Student’s t test: **P < 0.01, ****P < 0.0001.

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts